Laurus Labs Ltd.

₹1026

+ 13.35 (1.32%)

04:01 pm - close price

BSE: LAURUSLABS

NSE: LAURUSLABS

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 6.64Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.64Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 10.16Good: 20

🟡

Current Ratio

Bad: 1Current: 1.22Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 8.30Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.85Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 6.64Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.64Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 10.16Good: 20

🟡

Current Ratio

Bad: 1Current: 1.22Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 8.30Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.85Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1181.79	1224.45	1194.92	1439.67	1194.91
Expenditure+	1015.07	1036.58	1013.50	1198.18	1023.71
Other Income+	3.60	1.78	2.43	18.53	2.51
Operating Profit	166.72	187.87	181.42	241.49	171.20
Interest	39.19	42.39	50.82	50.50	49.19
Depreciation and Amortization	90.55	93.37	98.41	102.25	106.06
Profit Before Tax	38.97	51.69	32.79	106.97	18.93
Tax+	12.18	14.57	9.45	31.95	6.25
Net Profit	26.79	37.12	23.34	75.02	12.68

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	4813.51	4935.57	6040.55	5040.83	5553.96
Operational Expenses+	3262.83	3513.14	4448.36	4263.33	4498.68
Operating Profit	1550.68	1422.43	1592.19	777.50	1055.28
Other Income	23.66	15.30	6.00	26.34	75.10
OPM %	32.22	28.82	26.36	15.42	19.00
Depreciation and Amortisation	205.07	251.49	324.08	384.58	430.09
Interest	68.16	102.39	165.17	182.90	216.00
Profit Before Tax	1301.11	1083.85	1108.94	236.36	484.29
Tax	208.82	200.70	281.59	68.01	129.22
Net Profit	983.58	827.52	784.53	157.68	358.32

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	5750.69	6968.04	7660.40	8387.03	9335.57
Liabilities+	5750.69	6968.04	7660.40	8387.03	9335.57

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	733.00	911.10	993.90	665.69	601.65
Cash from Investing Activity	-940.99	-914.34	-996.06	-822.42	-681.72
Cash from Financing Activity	254.70	30.26	-26.64	249.83	39.28
Net Cash Flow	46.71	27.02	-28.80	93.10	-40.79
Opening Cash & Cash Equivalents	1.69	48.46	75.35	45.67	138.94
Closing Cash & Cash Equivalents	48.46	75.35	45.67	138.94	99.54

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	27.59	27.59	27.62	27.62	27.18	27.18	27.19	27.19	27.20	27.20
Public+	72.41	72.41	72.38	72.38	72.82	72.82	72.81	72.81	72.80	72.80
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	283678	280223	292905	292214	309063	324059	356830	382880	402640	417977

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	733.00	911.10	993.90	665.69	601.65
Cash from Investing Activity	-940.99	-914.34	-996.06	-822.42	-681.72
Cash from Financing Activity	254.70	30.26	-26.64	249.83	39.28
Net Cash Flow	46.71	27.02	-28.80	93.10	-40.79
Opening Cash & Cash Equivalents	1.69	48.46	75.35	45.67	138.94
Closing Cash & Cash Equivalents	48.46	75.35	45.67	138.94	99.54

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	4813.51	4935.57	6040.55	5040.83	5553.96
Operational Expenses+	3262.83	3513.14	4448.36	4263.33	4498.68
Operating Profit	1550.68	1422.43	1592.19	777.50	1055.28
Other Income	23.66	15.30	6.00	26.34	75.10
OPM %	32.22	28.82	26.36	15.42	19.00
Depreciation and Amortisation	205.07	251.49	324.08	384.58	430.09
Interest	68.16	102.39	165.17	182.90	216.00
Profit Before Tax	1301.11	1083.85	1108.94	236.36	484.29
Tax	208.82	200.70	281.59	68.01	129.22
Net Profit	983.58	827.52	784.53	157.68	358.32

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	5750.69	6968.04	7660.40	8387.03	9335.57
Liabilities+	5750.69	6968.04	7660.40	8387.03	9335.57

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1181.79	1224.45	1194.92	1439.67	1194.91
Expenditure+	1015.07	1036.58	1013.50	1198.18	1023.71
Other Income+	3.60	1.78	2.43	18.53	2.51
Operating Profit	166.72	187.87	181.42	241.49	171.20
Interest	39.19	42.39	50.82	50.50	49.19
Depreciation and Amortization	90.55	93.37	98.41	102.25	106.06
Profit Before Tax	38.97	51.69	32.79	106.97	18.93
Tax+	12.18	14.57	9.45	31.95	6.25
Net Profit	26.79	37.12	23.34	75.02	12.68

Ratios

Reported EPS

Bad: 2Current: 6.64Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.64Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 10.16Good: 20

🟡

Current Ratio

Bad: 1Current: 1.22Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 8.30Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.85Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 6.64Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.64Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 10.16Good: 20

🟡

Current Ratio

Bad: 1Current: 1.22Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 8.30Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 28.85Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	27.59	27.59	27.62	27.62	27.18	27.18	27.19	27.19	27.20	27.20
Public+	72.41	72.41	72.38	72.38	72.82	72.82	72.81	72.81	72.80	72.80
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	283678	280223	292905	292214	309063	324059	356830	382880	402640	417977

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Laurus Labs Ltd.

₹1026

+ 13.35 (1.32%)

04:01 pm - close price

BSE: LAURUSLABS

NSE: LAURUSLABS

Industry: Pharmaceuticals & Drugs

House: Private

Overview